Immune Focusing and Enhanced Neutralization Induced by HIV-1 gp140 Chemical Cross-Linking
Schiffner, T, Kong, L, Duncan, C J A, Back, J W, Benschop, J J, Shen, X, Huang, P S, Stewart-Jones, G B, DeStefano, J, Seaman, M S, Tomaras, G D, Montefiori, D C, Schief, W R, Sattentau, Q J
Published in Journal of Virology (01.09.2013)
Published in Journal of Virology (01.09.2013)
Get full text
Journal Article
Repeated vaginal administration of trimeric HIV-1 clade C gp140 induces serum and mucosal antibody responses
Cranage, M P, Fraser, C A, Stevens, Z, Huting, J, Chang, M, Jeffs, S A, Seaman, M S, Cope, A, Cole, T, Shattock, R J
Published in Mucosal immunology (01.01.2010)
Published in Mucosal immunology (01.01.2010)
Get full text
Journal Article
Cutting Edge: Expression of Functional CD94/NKG2A Inhibitory Receptors on Fetal NK1.1+Ly-49- Cells: A Possible Mechanism of Tolerance During NK Cell Development
Sivakumar, P. V, Gunturi, A, Salcedo, M, Schatzle, J. D, Lai, W. C, Kurepa, Z, Pitcher, L, Seaman, M. S, Lemonnier, F. A, Bennett, M, Forman, J, Kumar, V
Published in The Journal of immunology (1950) (15.06.1999)
Published in The Journal of immunology (1950) (15.06.1999)
Get full text
Journal Article
Broadly neutralizing antibodies suppress post-transcytosis HIV-1 infectivity
Lorin, V, Malbec, M, Eden, C, Bruel, T, Porrot, F, Seaman, M S, Schwartz, O, Mouquet, H
Published in Mucosal immunology (01.05.2017)
Published in Mucosal immunology (01.05.2017)
Get full text
Journal Article
Broadly neutralizing antibodies suppress post-transcytosis HIV-1 infectivity
Lorin, V, Malbec, M, Eden, C, Bruel, T, Porrot, F, Seaman, M S, Schwartz, O, Mouquet, H
Published in Mucosal immunology (01.05.2017)
Published in Mucosal immunology (01.05.2017)
Get full text
Journal Article
Comparison of the depth of vaccine-elicited HIV-1 Env epitope-specific CD8+ T lymphocyte responses
Hulot, SL, Korber, BT, Pantaleo, G, Tartaglia, J, Jacobs, B, Perdiguero, B, Gomez, CE, Esteban, M, Letvin, N, Seaman, MS, Haynes, B, Santra, S
Published in Retrovirology (13.09.2012)
Published in Retrovirology (13.09.2012)
Get full text
Journal Article
gld/gld mice are unable to express a functional ligand for Fas
Ramsdell, F, Seaman, M S, Miller, R E, Tough, T W, Alderson, M R, Lynch, D H
Published in European journal of immunology (01.04.1994)
Published in European journal of immunology (01.04.1994)
Get more information
Journal Article
P04-55 LB. Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes
Zolla-Pazner, S, Wrin, T, Seaman, MS, Yu, X, Wood, B, Self, S, Hioe, CE
Published in Retrovirology (22.10.2009)
Published in Retrovirology (22.10.2009)
Get full text
Journal Article
P04-10. Neutralization of Tier 1 and Tier 2 pseudoviruses by human anti-V3 monoclonal antibodies
Gorny, MK, Williams, C, O'Neal, T, Choudhary, AK, Luthra, K, Wood, B, Seaman, MS, Nyambi, P, Zolla-Pazner, S
Published in Retrovirology (22.10.2009)
Published in Retrovirology (22.10.2009)
Get full text
Journal Article
P04-09. Induction of cross-clade neutralizing antibodies with a prime/boost vaccine strategy focused on a neutralizing epitope
Zolla-Pazner, S, Kong, X, Cardozo, T, Hioe, C, Cohen, S, Jiang, X, Gorny, M K, Totrov, M, Pinter, A, Krachmarov, C, Seaman, MS, Wang, S, Lu, S
Published in Retrovirology (22.10.2009)
Published in Retrovirology (22.10.2009)
Get full text
Journal Article
P03-07. Autologous neutralizing antibodies that select viral escape variants emerge late after SIV infection of rhesus monkeys
Yeh, WW, Rahman, I, Hraber, P, Giri, A, Nevidomskyte, D, Coffey, RT, Asmal, M, Miljkovic, S, Whitney, JB, Keele, BF, Shaw, GM, Korber, BT, Seaman, MS, Letvin, NL
Published in Retrovirology (22.10.2009)
Published in Retrovirology (22.10.2009)
Get full text
Journal Article
OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector
Baden, LR, Dolin, R, O'Brien, KL, Abbink, P, La Porte, A, Seaman, MS, Choi, E, Tucker, R, Weitjens, M, Pau, MG, Goudsmit, J, Barouch, DH
Published in Retrovirology (22.10.2009)
Published in Retrovirology (22.10.2009)
Get full text
Journal Article
First-in-human phase 1 trial of the safety and immunogenicity of a recombinant adenovirus serotype 5 HVR48 (rAd5HVR48) HIV-1 vaccine
Walsh, SR, Seaman, MS, Johnson, JA, Tucker, RP, Krause, KH, Weijtens, M, Pau, MG, Goudsmit, J, Dolin, R, Barouch, DH, Baden, LR
Published in Retrovirology (13.09.2012)
Published in Retrovirology (13.09.2012)
Get full text
Journal Article
Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity
Huang, Yaoxing, Yu, Jian, Lanzi, Anastasia, Yao, Xin, Andrews, Chasity D., Tsai, Lily, Gajjar, Mili R., Sun, Ming, Seaman, Michael S., Padte, Neal N., Ho, David D.
Published in Cell (16.06.2016)
Published in Cell (16.06.2016)
Get full text
Journal Article
CD40 ligand acts as a costimulatory signal for neonatal thymic gamma delta T cells
Ramsdell, F, Seaman, MS, Clifford, KN, Fanslow, WC
Published in The Journal of immunology (1950) (01.03.1994)
Published in The Journal of immunology (1950) (01.03.1994)
Get full text
Journal Article
Neutralization activity in a geographically diverse East London cohort of human immunodeficiency virus type 1-infected patients: clade C infection results in a stronger and broader humoral immune response than clade B infection
DREJA, Hanna, O'SULLIVAN, Eithne, MONTEFIORI, David, SEAMAN, Michael S, ANDERSON, Jane, ORKIN, Chloe, MCKNIGHT, Aine, PADE, Corinna, GREENE, Kelli M, HONGMEI GAO, AUBIN, Keith, HAND, James, ISAKSEN, Are, D'SOUZA, Carl, LEBER, Werner
Published in Journal of general virology (01.11.2010)
Published in Journal of general virology (01.11.2010)
Get full text
Journal Article